Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Science Policy Alerts

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 19 August 1988:
Vol. 241. no. 4868, pp. 961 - 965
DOI: 10.1126/science.2841761

Articles

Science, Vol 241, Issue 4868, 961-965
Copyright © 1988 by American Association for the Advancement of Science


articles

Concerted nonsyntenic allelic loss in human colorectal carcinoma

DJ Law, S Olschwang, JP Monpezat, D Lefrancois, D Jagelman, NJ Petrelli, G Thomas, and AP Feinberg

Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor 48109.

Familial polyposis coli (FPC) is caused by an autosomal dominant gene on chromosome 5, and it has been proposed that colorectal cancer in the general population arises from loss or inactivation of the FPC gene, analogous to recessive tumor genes in retinoblastoma and Wilms' tumor. Since allelic loss can be erroneously scored in nonhomogeneous samples, tumor cell populations were first microdissected from 24 colorectal carcinomas, an additional nine cancers were engrafted in nude mice, and nuclei were flow-sorted from an additional two. Of 31 cancers informative for chromosome 5 markers, only 6 (19%) showed loss of heterozygosity of chromosome 5 alleles, compared to 19 of 34 (56%) on chromosome 17, and 17 of 33 (52%) on chromosome 18. Therefore, it appears that (i) FPC is a true dominant for adenomatosis but not a common recessive gene for colon cancer; and (ii) simple Mendelian models involving loss of alleles at a single locus may be inappropriate for understanding common human solid tumors.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Mouse Skin Models for Carcinogenic Hazard Identification: Utilities and Challenges.
D. Lynch, J. Svoboda, S. Putta, H. E. J. Hofland, W. H. Chern, and L. A. Hansen (2007)
Toxicol Pathol 35, 853-864
   Abstract »    Full Text »    PDF »
Development and initial characterization of several new inbred strains of SENCAR mice for studies of multistage skin carcinogenesis.
L. G. Coghlan, I. Gimenez-Conti, H. E. Kleiner, S. M. Fischer, J. E. Rundhaug, C. J. Conti, T. J. Slaga, and J. DiGiovanni (2000)
Carcinogenesis 21, 641-646
   Abstract »    Full Text »    PDF »
Alternative genetic pathways in colorectal carcinogenesis.
S. Olschwang, R. Hamelin, P. Laurent-Puig, B. Thuille, Y. De Rycke, Y.-J. Li, F. Muzeau, J. Girodet, R.-J. Salmon, and G. Thomas (1997)
PNAS 94, 12122-12127
   Abstract »    Full Text »    PDF »
Microsatellite instability in cancer of the proximal colon.
S. Thibodeau, G Bren, and D Schaid (1993)
Science 260, 816-819
   Abstract »    PDF »
Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene.
L. Su, K. Kinzler, B Vogelstein, A. Preisinger, A. Moser, C Luongo, K. Gould, and W. Dove (1992)
Science 256, 668-670
   Abstract »    PDF »
Allelotype of colorectal carcinomas.
B Vogelstein, E. Fearon, S. Kern, Hamilton SR, A. Preisinger, Y Nakamura, and R White (1989)
Science 244, 207-211
   Abstract »    PDF »
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.
S. Baker, E. Fearon, J. Nigro, Hamilton SR, A. Preisinger, J. Jessup, P vanTuinen, D. Ledbetter, D. Barker, Y Nakamura, et al. (1989)
Science 244, 217-221
   Abstract »    PDF »



ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)